Breast Implant-Associated Anaplastic Large Cell Lymphoma: An Update
The occurrence rate of BIA-ALCL following breast augmentation with textured implants is variable, with the reported lifetime risk ranging from 1 in 355 to 1 in 86,029 patients.
The occurrence rate of BIA-ALCL following breast augmentation with textured implants is variable, with the reported lifetime risk ranging from 1 in 355 to 1 in 86,029 patients.
Postoperative antibiotic prescriptions are associated with reduced rates of infections after facial plastic surgery.
Persistent and prolonged opioid use occur after plastic and reconstructive surgical procedures.
Women with saline or silicone gel-filled breast implants may have a small but significant risk for developing anaplastic large cell lymphoma.
The patient’s pain and swelling failed to resolve despite previous hospitalization and IV cephalosporin therapy.
Is microdermabrasion a good alternative glycol acid or other chemical peels?
Dogs provide love and companionship for millions, but accidents happen. Find out what you and your patients can do to prepare for them.